Cargando…
Amyloid β precursor protein silencing attenuates epithelial-mesenchymal transition of nasopharyngeal carcinoma cells via inhibition of the MAPK pathway
Advances in the treatment of nasopharyngeal carcinoma (NPC) have significantly improved the local control rate; however, distant metastasis remains a principal cause of mortality. Previous studies have demonstrated that the expression levels of amyloid β precursor protein (APP) are increased in NPC....
Autores principales: | Xu, Jin, Ying, Yin, Xiong, Gaoyun, Lai, Liqin, Wang, Qingliang, Yang, Yue |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6580003/ https://www.ncbi.nlm.nih.gov/pubmed/31180550 http://dx.doi.org/10.3892/mmr.2019.10293 |
Ejemplares similares
-
Knockdown of serpin peptidase inhibitor clade C member 1 inhibits the growth of nasopharyngeal carcinoma cells
por: Xu, Jin, et al.
Publicado: (2019) -
Curcumol attenuates epithelial-mesenchymal transition of nasopharyngeal carcinoma cells via TGF-β1
por: Yan, Dazhong, et al.
Publicado: (2018) -
LncRNA FOXP4-AS1 silencing inhibits metastasis and epithelial–mesenchymal transition in nasopharyngeal carcinoma via miR-136-5p/MAPK1
por: Yan, Jin, et al.
Publicado: (2023) -
Repression of Smad3 by silencing Robo1 attenuates epithelial-mesenchymal transition in tracheobronchial stenosis
por: He, Chunyan, et al.
Publicado: (2023) -
Silencing Smad4 attenuates sensitivity of colorectal cancer cells to cetuximab by promoting epithelial-mesenchymal transition
por: Lin, Zhenlv, et al.
Publicado: (2019)